NCT00542295View on ClinicalTrials.gov

Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

September 30, 2008

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

alverine citrate and simeticone

DRUG

placebo

Trial Locations (18)

1083

Budapest

1106

Budapest

1125

Budapest

1204

Budapest

3501

Miskolc

3529

Miskolc

4032

Debrecen

5700

Gyula

6720

Szeged

8000

Székesfehérvár

8600

Siofolk

9024

Győr

85-168

Bydgoszcz

40-752

Katowice

55-200

Oława

71-252

Szczecin

50-556

Wroclaw

51-149

Wroclaw

Sponsors
All Listed Sponsors
lead

Laboratoires Mayoly Spindler

INDUSTRY